## Adverse Effects and Complications of Chronic Opioid Therapy ### Opioid-Induced Constipation (OIC) **Key Point:** Constipation is one of the most common and persistent adverse effects of opioids: - Mediated by μ-receptors in the enteric nervous system (myenteric and submucosal plexuses) - Increases colonic muscle tone and reduces propulsive contractions - Tolerance does NOT develop (unlike analgesia) - Requires prophylactic stool softeners, osmotic laxatives, and/or peripherally-acting μ-antagonists (methylnaltrexone, naloxegol) ### Tolerance vs. Respiratory Depression **High-Yield:** A critical distinction in opioid pharmacology: - **Tolerance develops to:** analgesia, euphoria, sedation, nausea (within days to weeks) - **Tolerance develops slowly to:** respiratory depression - **Clinical consequence:** Patients escalate doses to maintain analgesia, but respiratory depression risk increases disproportionately → overdose risk - This is why opioid-related deaths spike with dose escalation in chronic users **Mnemonic:** **TARN** — Tolerance Absent to Respiratory depression, develops to Analgesia, Reward, Nausea ### Opioid-Induced Hyperalgesia (OIH) — The Trap **Warning:** This is the key distractor. OIH is: - A **paradoxical increase in pain sensitivity** (hyperalgesia) that occurs with chronic high-dose opioids - Mediated by **NMDA receptor activation** and neuroinflammation (NOT mu-receptor mechanisms) - **NOT reversed by naloxone** (because it is not a mu-receptor-mediated effect) - Managed by dose reduction, opioid rotation, or addition of NMDA antagonists (ketamine, memantine) **Clinical Pearl:** OIH is distinct from tolerance. A patient may develop both: tolerance (requiring higher doses for the same analgesia) AND hyperalgesia (paradoxical worsening of pain). This creates a clinical dilemma where escalating doses worsen the problem. ### Physical Dependence and Withdrawal **Key Point:** Physical dependence is a state of neuroadaptation: - Withdrawal syndrome appears **6–12 hours after the last dose** of short-acting opioids (morphine, heroin) - Withdrawal from long-acting opioids (methadone) may be delayed 24–48 hours - Symptoms: anxiety, insomnia, myalgias, lacrimation, rhinorrhea, diaphoresis, diarrhea, mydriasis - **Prevention:** Gradual dose tapering (not abrupt cessation) - **Management:** Reinstate opioid or use clonidine, lofexidine, or buprenorphine ### Comparison: Tolerance, Dependence, and Addiction | Feature | Tolerance | Physical Dependence | Addiction | | --- | --- | --- | --- | | **Definition** | Reduced response to repeated doses | Neuroadaptation; withdrawal on cessation | Compulsive use despite harm | | **Onset** | Days to weeks | Days to weeks | Variable; behavioral | | **Reversal** | Dose escalation or opioid rotation | Gradual tapering | Behavioral + pharmacological | | **Naloxone effect** | No direct reversal | Precipitates acute withdrawal | No direct effect | **Clinical Pearl:** A patient can be physically dependent without being addicted, and vice versa. Dependence is a predictable pharmacological consequence; addiction is a behavioral disorder.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.